A therapy that combines simvastatin with another drug called ezetimibe has been linked to slightly raised levels of cancer in an international study whose results were published in the New England Journal of Medicine this week. There was also concern raised in the study about the drugs effectiveness in delaying the progression of aortic valve disease.
Media round up
Radio New Zealand: Cholesterol lowering drug under scrutiny
The Daily Express: Cholesterol pill linked to higher risk of cancer
The Daily Mirror: Specialist’s cancer fear over drug
NEJM Editorial: Ezetimibe and cancer – an uncertain association
To speak to an expert on this issue, contact the Science Media Centre on 04 499 5476 or email@example.com